Skip to main content

Capital Group Increases Stake in AstraZeneca

Tipranks - Tipranks - Tue Nov 18, 2025

Meet Your ETF AI Analyst

An announcement from AstraZeneca ( (GB:AZN) ) is now available.

The Capital Group Companies, Inc. has increased its voting rights in AstraZeneca PLC to 5.017815%, crossing a significant threshold. This change in voting rights could impact AstraZeneca’s governance and decision-making processes, potentially influencing its strategic direction and affecting stakeholders.

More about AstraZeneca

AstraZeneca PLC is a UK-based pharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in areas such as oncology, cardiovascular, renal, and metabolism, as well as respiratory and immunology.

For a thorough assessment of AZN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).